The Global Fund has released its 2023 Eligibility List, which details countries and disease components that are eligible for the 2023-2025 allocations.
This round’s eligibility was determined by a country’s income classification and disease burden. All low and lower- middle income countries are eligible, regardless of disease burden. Upper-middle income countries must have at least a ‘high’ burden of disease to be eligible for Global Fund financing5.
Twenty nine (29) Asia and the Pacific countries are eligible for funding under the 2020-2022 Funding Cycle. These are Afghanistan, Bangladesh, Bhutan, Cambodia, Fiji (except for malaria), India, Indonesia, Kiribati (except for malaria), DPR Korea, Lao PDR, Malaysia (except for malaria), Maldives (except for malaria), Marshall Islands (except for malaria), Mongolia (except for malaria), Myanmar, Nepal, Pakistan, Papua New Guinea, Philippines, Samoa (except for malaria), Sao Tome and Principe, Solomon Islands, Sri Lanka (except for malaria), Thailand, Timor Leste, Tonga (except for malaria), Tuvalu (except for malaria), Vanuatu, and Viet Nam. Fiji is now eligible again for TB and HIV. Nauru, on the other hand, became ineligible.
A multi-country application is only eligible for funding where the majority (at least 51 percent) of countries included in the application would be eligible to submit their own request for funding for that same disease through a single-country application. In the region, there are two expected multicountry grants that will be continued: the RAI grant across Mekong countries (malaria), and the Western Pacific grant covering the Pacific (TB, HIV, and malaria where applicable).
For more information, visit The Global Fund website.